Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Vivatlac Synbiotic on the Gut Microbiota of Patients With Irritable Bowel Syndrome - A Randomized, Double-blind, Placebo-Controlled, 12 Weeks Clinical Trial

NCT07235228 is registered in ClinicalTrials.gov with The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz as lead sponsor.

NCT NCT07235228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07235228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Vivatlac Synbiotic on the Gut Microbiota of Patients With Irritable Bowel Syndrome - A Randomized, Double-blind, Placebo-Controlled, 12 Weeks Clinical Trial
Lead sponsor
The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2025
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome